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Abstract
Genetic mechanisms have been implicated as a cause of some cases of male infertility.  Recently, 10 novel genes 
involved in human spermatogenesis were identified by microarray analysis of human testicular tissue.  One of these 
is spermatogenesis-associated 17 (SPATA17).  To investigate whether defects in the SPATA17 gene are associated 
with azoospermia due to meiotic arrest, a mutational analysis was conducted, in which the SPATA17 coding regions 
of 18 Japanese patients with this condition were sequenced.  A statistical analysis was carried out that included 18 
patients with meiotic arrest, 20 patients with Sertoli-cell-only syndrome (SCOS) and 96 healthy control men.  No 
mutations were found in SPATA17.  However, three coding single nucleotide polymorphisms (cSNPs: SNP1–SNP3) 
were detected in the patients with meiotic arrest.  No significant differences in the genotype or allele frequencies 
of SNP1 and SNP2 were found between patients with meiotic arrest and the others.  However, the frequency of the 
SNP3 allele was significantly elevated in the meiotic arrest group (P < 0.05).  This study suggests that SPATA17 may 
play a critical role in human spermatogenesis, especially in meiosis.
Asian Journal of Andrology (2009) 11: 623–628.  doi: 10.1038/aja.2009.30; published online 1 June 2009
Keywords: azoospermia, meiosis, polymorphism, SNP, SPATA17
1    Introduction
Genetic causes of azoospermia include chromosomal 
abnormalities, Y-chromosome microdeletions and several 
specific gene mutations/deletions affecting genes, 
such as DAZ, RBMY, USP9Y and SYCP3 [1–5].  As 
Y-chromosome deletions account for only 16.0% of 
men with infertility [6], azoospermia in many infertile 
men may be caused by autosomal gene mutations. 
Genetic polymorphisms may also increase susceptibility 
to some forms of male infertility.  For example, the 
human MEI1 and USP26 genes are linked to male 
infertility [7, 8].  Further analysis, including promoter 
studies, have been conducted on human and mouse 
spermatogenesis.  For example, polymorphisms in the 
human UBE2B gene are associated with the human 
azoospermic/oligozoospermic population [9, 10].  It is 
suspected that more genes play critical roles in human 
spermatogenesis.
Analysis of SPATA17 in human azoospermia
Toshinobu Miyamoto et al.
Asian Journal of Andrology  |  http://www.asiaandro.com;  aja@sibs.ac.cn 
624
npg
semen analyses obtained after 5–7 days of sexual 
abstinence and examination of a centrifuged semen 
pellet.  Patients with defective spermatogenesis after 
an infection, or because of obstruction of the seminal 
tract, pituitary failure or other causes of possible 
testicular damage revealed at clinical examination, 
were excluded from the study.  Final diagnoses were 
established by histological examination.  Histological 
diagnosis was conducted on more than 20 testicular 
specimens.  Histological diagnosis was carried out by 
two pathologists and two urologists at Osaka University. 
Primary spermatocytes were the most mature cell types 
present.  No postmeiotic cells (round haploid spermatids, 
elongating spermatids or mature spermatozoa) were 
present.  The average hormone levels in the patients 
with meiotic arrest were as follows: leutinizing 
hormone: 5.28 mIU mL-1, follicle stimulating hormone 
(FSH): 15.6 mIU mL-1, testosterone: 2.92 ng mL-1 
and inhibin B: 49.0 pg mL-1.  Chromosome analysis of 
peripheral lymphocytes showed a karyotype of 46, XY 
in all patients.  In addition, no patients analysed had Y 
chromosome microdeletions.  A total of 18 Japanese 
patients with azoospermia due to meiotic failure 
were included in this study.  A total of 96 healthy and 
pregnancy-proven fertile controls and 20 patients with 
azoospermia due to SCOS were also examined.  All 
subjects were Japanese and gave informed consent for 
molecular blood analysis.  This study was approved by 
a local ethics committee.
2.2  Mutation screening
We screened 18 Japanese patients diagnosed as 
having azoospermia due to meiotic arrest for mutations 
in the SPATA17 gene.  The full-length cDNA sequences 
were compared with human genomic sequences 
(NW_926794.1) by BLAST, and all exon–intron 
borders were determined.  The following primers were 
used for mutational analysis.  The sequences of the 
oligonucleotide primers are listed in Table 1.
Primers of SPATA17:
Exon 1: E1F1, E1F2, E1R1 and E1R2;
Exon 2: E2F1, E2F2, E2R1 and E2R2;
Exon 3: E3F1, E3F2, E3R1 and E3R2;
Exon 4: E4F1, E4F2, E4R1 and E4R2;
Exon 5: E5F1, E5F2, E5R1 and E5R2;
Exon 6: E6F1, E6F2, E6R1 and E6R2;
Exon 7: E7F1, E7F2, E7R1 and E7R2;
Exon 8: E8F1, E8F2, E8R1 and E8R2;
Defective meiosis during spermatogenesis is a known 
cause of azoospermia; however, the mechanisms leading 
to defective meiosis remain unknown.  Meiosis is a 
fundamental process in sexually reproducing species that 
permits genetic exchange between the maternal and the 
paternal genomes [11].  The genetic regulation of meiosis 
in mammals is poorly understood when compared with 
that in lower eukaryotes such as yeast.
Several genes critical for mouse meiosis, such as 
Fkbp6, Scp3 (Sycp3), Spo11, Msh4 and Msh5, have been 
identified by disruption experiments in embryonic stem 
cells [12–16].  However, the number of human genes 
identified as causing azoospermia is quite small.  The 
primary reason for this low number is that a reverse 
genetic approach is required to identify human disease-
causing genes.  Another reason is that biological 
discrepancies exist between mice and humans.  To 
work around this latter reason, microarray analyses 
have been carried out with normal and abnormal human 
tissue.  In 2006, 10 novel genes involved in human 
spermatogenesis were identified by microarray analysis 
of testicular tissue [17].  Microarray analysis was 
carried out using normal, meiotic arrest and SCOS 
(Sertoli-cell-only syndrome) testis tissues.  One gene 
that was identified in the comparison between the 
testis tissues of normal and meiotic arrest azoospermia 
patients was spermatogenesis-associated 17 (SPATA17). 
SPATA17 is also called MSRG-11.  The mouse Spata17 
(Msrg-11) cDNA was isolated in 2005 and recognized 
as a member of the calmodulin (CaM)-binding protein 
family [18].  It is strongly expressed in adult mouse 
testes, but weakly expressed in the spleen and thymus. 
This protein contains three short CaM-binding motifs 
containing conserved Ile and Gln residues (IQ motifs). 
It has been suggested that the mouse Spata17 gene 
might play an important role in the development of 
mouse testes, and it is a candidate gene for testes-
specific apoptosis [18, 19].  However, the literature 
does not contain any reports on the role of the human 
SPATA17 gene in spermatogenesis.  In this study, we 
carried out a mutational analysis of human SPATA17 
using the genomic DNA of Japanese patients with 
azoospermia due to meiotic arrest.
2    Materials and methods
2.1  Patients and controls
Azoospermia was confirmed by two consecutive 
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Exon 9: E9F1, E9F2, E9R1 and E9R2;
Exon 10: E10F1, E10F2, E10R1 and E10R2
Nested PCRs were carried out using primers for 
each intronic region (Table 1) and 10-fold diluted 
first PCR products as templates.  The first PCR was 
carried out in a final volume of 25 mL, consisting of 
genomic DNA (10 ng), dNTPs (0.32 m mol L-1 each), 
primers (0.2 mm mol L-1 each), Taq polymerase (0.2 
mm mol L-1, 0.625 IU) and reaction buffer containing 
MgCl2.  The first PCRs were carried out as follows: 
initial denaturation at 95 ºC for 150 s, followed by 32 
cycles of denaturation at 95 ºC for 30 s, annealing at 
(primers’ Tm –5 ºC) for 90 s and extension at 72 ºC for 
90 s.  Nested PCRs were carried out for 20 cycles under 
the same conditions as above; however, 2 mL of 10-
fold diluted first PCR products were used as templates. 
Nested PCR products were purified using a QIAquick 
PCR Purification kit (Qiagen; Tokyo, Janpan), and each 
product was sequenced directly.  To confirm the role of 
the detected polymorphisms in azoospermia, the coding 
region of the SPATA17 gene of 96 healthy and fertile 
control individuals and the 20 patients with SCOS were 
also analysed by direct sequencing.
2.3  Genotyping and statistical analyses
2.3.1  Single-locus analysis
To investigate the role of SPATA17 polymorphisms 
in azoospermia, Fisher’s exact test was used to determine 
meaningful differences.  P < 0.05 was considered to be 
statistically significant.  Hardy–Weinberg equilibrium 
(HWE) was tested using the SNPAlyze software 
(DYNACOM; Chiba, Japan).  All possible two-
way combinations of SNPs were tested for linkage 
disequilibrium (LD) with the absolute value of the 
correlation coefficient (D').  The P values were 
determined by c 2 approximation.  Significance was 
established at P < 0.05, as described above.  Haplotype 
frequencies were estimated by the method of maximum 
Table 1.  Sequences of oligonucleotide primers used for mutational screening of SPATA17.
 Forward primer Reverse primer
 Exon 1 E1F1:5'-GTTTACTGCTTTCCCCTTCC-3' E1R1:5'-GATTCTCCTGCCTCAGCCTC-3'
  E1F2:5'-CTCGCAGTAGAGACAGAGAC-3' E1R2:5'-GAAACTCCCGCTGAGGAACA-3'
 Exon 2 E2F1:5'-GGTGCCTTCCGTTCATTATC-3' E2R1:5'-TCACTGCAAACTTCGCCTTC-3'
  E2F2:5'-CTCACATCTGGATCACTGAC-3' E2R2:5'-GCTGATCTCAAACTCCTGAC-3'
 Exon 3 E3F1:5'-CTCCCTGGTTCAAGTGATTC-3' E3R1:5'-GTTCTGGGCAAGGCATTAGC-3'
  E3F2:5'-CTCAGCCTCCAGAATAGCCA-3' E3R2:5'-CCACTCTCAAAAAGCTCACC-3'
 Exon 4 E4F1:5'-GGATCAGACCAGGCAATTCA-3' E4R1:5'-GTTCACCCCAGCACTTTCAG-3'
  E4F2:5'-CCATCACTGCATCCATATCC-3' E4R2:5'-CAGAAACCGAGTTCAAGCTC-3'
 Exon 5 E5F1:5'-CTCTCTGAAGCCCTAACTTG-3' E5R1:5'-TGGTGAAACCCCGTCTCTAC-3'
  E5F2:5'-CAGGAAGTGGAAATGGTAGG-3' E5R2:5'-GAGGAGGAGATTGCAGTGAG-3'
 Exon 6 E6F1:5'-CTCTGCTTTCCTCAGATACC-3' E6R1:5'-CTCTATGAAGCCGCTGTCAC-3'
  E6F2:5'-GGATATGGATGATGGTTGCC-3' E6R2:5'-TGTCCCATTCAGCCTGCTAG-3'
 Exon 7 E7F1:5'-GCTGTGTGACAGATAGGAAC-3' E7R1:5'-CTCTACCCTTTAGCCTCAGG-3'
  E7F2:5'-GTCCACCTCTGGTTAAGAAC-3' E7R2:5'-CACACAAATGGCCAATAGGC-3'
 Exon 8 E8F1:5'-CCCACAGTCTTCACTCAGTG-3' E8R1:5'-CTTGGCTAAGTCTGAGAAGC-3'
  E8F2:5'-AGGGCTGTTGGAAAGCTATG-3' E8R2:5'-GCCTGAGAGAAAGATGTCTG-3'
 Exon 9 E9F1:5'-CTGTACTGGCTGTCCTTTTG-3' E9R1:5'-CTGGTCCCTTGGGATTAGTG-3'
  E9F2:5'-AGTGGCAGAGGTTGAAATGG-3' E9R2:5'-GTGCATATGACACTCAGGAG-3'
 Exon 10 E10F1:5'-GTGGATATGCCTGAGGTTTG-3' E10R1:5'-AGCCTAGTGCTTTCTCCTTG-3'
  E10F2:5'-GACTTGCTTGCAGGTGACAC-3' E10R2:5'-GGAGAATCACTTGAACCTGG-3'
Abbreviation: SPATA17, spermatogenesis-associated 17 gene.
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were 0.50/0.50 in the patient group and 0.193/0.807 in 
the control group, and this difference was significant 
(P < 0.05).  The number of GG homozygotes at the 
SNP3 site was markedly higher in the patient group. 
In addition, at the c.608G/A site, the proportions of 
GG homozygotes/GA heterozygotes/AA homozygotes 
in the SCOS group were 0.00/0.15/0.85.  The allelic 
frequencies of c.608G/A were 0.075/0.925 in the SCOS 
group.  The allele frequencies were different between 
the patient group with meiotic arrest and the patient 
group with SCOS (P < 0.05).  In the HWE test of the 
distribution of genotypes for each SNP of the patient 
group, SNP2 showed a meaningful deviation (P < 0.05). 
Haplotype analysis revealed that the haplotype frequencies 
estimated for all three polymorphisms in the groups were 
similar (P > 0.05).  Haplotype estimation and LD analysis 
also revealed no critical differences (P > 0.05).  In 
addition, average hormone levels were compared 
between the patients in each of the three SNP3 genotype 
groups (Table 3).  This statistical analysis revealed no 
meaningful differences between the groups (P > 0.05), with 
the exception that the level of FSH in GG homozygotes 
was higher relative to the normal range in Japanese 
men.
4    Discussion
Recently, several novel genes that are downregulated 
likelihood based on the expectation–maximization 
algorithm under the assumption of HWE.  The LD and 
haplotype frequencies were tested using the SNPAlyze 
software.  P values were determined by c2 approximation; 
Significance was determined at the P <  0.05.
3    Results
Mutation analysis of the SPATA17 gene revealed three 
nucleotide changes among the 18 patients: c.340A/G in 
exon 5, c.429C/T in exon 6 and c.608A/G in exon 7. 
However, all of these changes were also observed in the 
96 control individuals, indicating that they are coding 
single nucleotide polymorphisms (cSNPs).  Comparison 
of our results with the NCBI dbSNP database revealed 
that, of the three SNPs, only c.429C/T was novel (Table 
2).  Among SNP1 (c.340A/G), SNP2 (c.429C/T) and 
SNP3 (c.608A/G), only SNP1 is non-synonymous 
(tyrosine to cysteine).
Genotyping of the SPATA17 SNP alleles in the 18 
patients and 96 controls revealed that the genotype 
distribution and the allelic frequency of SNP3 were 
significantly different between the two groups (Table 
2).  At the c.608G/A site, the proportions of GG 
homozygotes/GA heterozygotes/AA homozygotes in 
the patient group were 0.333/0.333/0.333 and those in 
the control group were 0.031/0.323/0.646 (P < 0.05). 
The allelic frequencies of c.608G/A in the two groups 
Table 2.  Genotype and allele frequencies of three coding single nucleotide polymorphisms (cSNPs) in the SPATA17 gene in 18 
azoospermic patients with meiotic arrest, control individuals and in 20 azoospermic patients with SCOS.
SNPs




  Genotype/total no of samples (%) Minor allele/total no of the chromosomes (%) 
  (G)  Meiotic arrest  Controls      SCOS (A) Meiotic arrest Controls SCOS
  P value P value 
SNP1 340G/A Tyr/Cys  GA   4/18 (22.22)    7/96 (7.29) G       4/36 (11.11)   7/192 (3.65) 
       0.071   0.0762 
SNP2 429T/C Synonymous  TC   2/18 (11.11)  24/96 (25.00)     
       0.235     
  TT   0/18 (0.00)     2/96 (2.08) T       2/36 (5.56)       28/192 (14.58)
       1.00   0.183
SNP3 608G/A Synonymous  GA   6/18 (33.33)  31/96 (32.29)     3/20 (15.0)    
       0.337         0.461    
  GG   6/18 (33.33)     3/96 (3.13)    17/20 (85.0)  G     18/36 (50.00)     37/192 (19.27)   3/40 (7.50)
       0.00026*         0.014   0.00022*          0.0024*
Abbreviations: SCOS, Sertoli-cell-only syndrome; SPATA17, spermatogenesis-associated 17; SNP, single nucleotide polymorphism. (G) 
and (A) reveal genotype and allele, respectively. *Statistically significant.
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in the testicular tissues of infertile men were identified 
by microarray analysis [17].  One of these genes is 
SPATA17, which is downregulated in the testes of 
patients with azoospermia due to meiotic arrest.  The 
mouse Spata17 gene is a member of the CaM-binding 
protein family, and it has been suggested that it might 
play a critical role in spermatogenetic cell apoptosis in 
mice [18,19].
We could not detect any SPATA17 mutations that 
were directly causative of azoospermia or that were 
limited to the 18 patients with meiotic arrest.  Instead, 
we identified three cSNPs in the gene.  This association 
study revealed that the allele frequencies of SNP3 
(c.608A/G) were significantly different between the 
patients with meiotic arrest, and both the controls 
and the patients with SCOS.  These findings suggest 
that the A allele at nucleotide 608 in exon 7 or its 
flanking region may play a role in the disruption of 
spermatogenesis in Japanese patients.  However, the 
encoded amino acid is not affected.  Thus, the function 
of SNP3 is unknown.  We believe that the patient group 
of 18 men is far too small for an association study. 
However, azoospermia due to meiotic arrest is very 
rare, and our histological diagnostic criteria were very 
strict.  We have DNA samples from more than 5000 
patients with azoospermia; however, only 18 patients 
had azoospermia due to meiotic arrest.  We carried out 
TESE (testicular sperm extraction) on > 5000 men, and 
> 70% of them have sperm in their testis.  However, we 
could not find sperm in any of the patients in this study, 
even in the testes.
Recently, we showed that the human PRDM9 
(MEISETZ) gene might play an important role in human 
spermatogenesis [20].  The patient group in that study 
was also used in this study.  We found SNP2 in one of 
the patients and SNP3 in two of the patients displaying 
PRDM9 SNPs.  However, these three patients revealed 
no variation in SNP3 of SPATA17.  Therefore, the 
relationship between the PRDM9 SNPs and SPATA17 
SNP3 remains unknown.
In vitro fertilization has been proven to be an 
efficient means of resolving infertility due to female 
factors [21]; however, it is less effective for severe 
oligospermia in the male partner [22].  Although TESE–
intracytoplasmic sperm injection is now carried out in 
patients with azoospermia, it cannot benefit patients 
in whom the absence of spermatozoa in their testes 
is because of a complete failure in spermatogenesis. 
Therefore, a treatment for infertility due to non-
obstructive azoospermia is a pre-eminent topic for 
assisted reproductive technology.
In conclusion, this is the first report showing 
that SPATA17 SNPs may predispose men to a defect 
in spermatogenesis, although the mechanism of 
involvement of the SNPs in azoospermia remains 
unclear.  Our results may also promote a better 
understanding of the molecular basis of early meiotic 
arrest as a cause of non-obstructive azoospermia.  It 
remains to be confirmed whether this association 
is seen in a large number of samples and in similar 
patients from other ethnic groups, although men with 
azoospermia due to meiotic arrest are very rare in any 
ethnic group.
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